MedTrace Logo

Diabetes-Specific Formula in Individuals With Type 2 Diabetes

NCT04303754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-12-07

No results posted yet for this study

Summary

This study will be conducted using a randomized, controlled, crossover design with three treatments. The purpose of the study is to determine the effects of diabetes-specific formula on glycemic control in individuals with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Diabetes-Specific Formula

Other: Diabetes Specific Formula

OTHER

Bread with Spread

Other: White Bread with Spread

OTHER

Rice Porridge

Other: Rice Porridge

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Agnes Siew Ling Tey, Ph.D. · Abbott Nutrition

  • Norlaila Mustafa, MD. · Universiti Kebangsaan Malaysia Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-24
Primary Completion
2022-10-19
Completion
2022-10-19

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04303754 on ClinicalTrials.gov